CA 19-9 Tumour Marker Test in Singapore

Key Takeaways

  • A CA 19-9 result under 37 U/mL is generally considered within the normal range. Reference ranges vary by laboratory and assay, so use your own report.
  • A level above 37 U/mL is elevated and warrants further evaluation. On its own it does not diagnose cancer.
  • A level above 1000 U/mL is strongly associated with pancreatic cancer, though very high readings can occasionally occur in non-cancerous conditions, and a definitive diagnosis still requires further evaluation.
  • CA 19-9 is used mainly to support diagnosis and to monitor treatment, not as a stand-alone screening test. Results are interpreted by your doctor alongside imaging and other findings.

The CA 19-9 tumour marker test is a blood test that measures the level of CA 19-9, a protein that can be raised in certain cancers, most often pancreatic cancer, and in some non-cancerous conditions. This page explains what the test measures, what the numbers mean, who it is for, what it costs in Singapore, and how a FeM Surgery specialist can help you understand a result.

What Is a CA 19-9 Test?

CA 19-9, also called carbohydrate antigen 19-9, is a mucin-type glycoprotein produced by both cancerous and non-cancerous cells. Its level tends to be higher in certain cancers, most commonly pancreatic cancer, and it can also rise in cancers of the bile ducts, stomach and colon, as well as in benign conditions such as pancreatitis, gallstones and liver disease. In simple terms, CA 19-9 is a blood marker that helps doctors support a diagnosis and follow how a known cancer responds to treatment, rather than a routine screening test for the general population.

 

One important point is often missed: roughly 5 to 10 percent of people have a Lewis-negative blood group type and produce little or no CA 19-9. In these individuals the test can read low or undetectable even when disease is present, so a normal result does not rule out cancer. This is one reason CA 19-9 is typically interpreted alongside symptoms, imaging and other tests.

Specifications at a Glance

A quick reference for what the test involves. Exact figures depend on the laboratory and analyser used.

Item Typical Detail
Reference interval Commonly under 37 U/mL; some Singapore laboratories report a tighter interval on certain analysers. Always read your own report.
Assay family Immunoassay (for example electrochemiluminescence immunoassay).
Specimen A venous blood sample, usually from the arm.
Fasting Not usually required; follow any instruction from your doctor.
Indicative turnaround Often a few working days, depending on the laboratory.
Reported as Units per millilitre (U/mL).

CA 19-9 Normal Range and Results

The most common question people have is what their number means. As a general guide:

 

Band Typical reading What it may mean
Normal Under 37 U/mL Within the usual range. Does not exclude disease, especially in Lewis-negative individuals.
Borderline / mildly raised Around 37 to 100 U/mL Can occur with benign conditions such as pancreatitis, gallstones, jaundice or liver disease, as well as some cancers. Needs clinical context.
Elevated Above 100 U/mL More likely to prompt further imaging and review, particularly with relevant symptoms.
Markedly elevated Above 1000 U/mL Often strongly associated with pancreatic cancer, though very high readings can rarely occur in non-cancerous disease. Prompt specialist assessment.

 

For people already under treatment, the trend over time usually matters more than a single reading. A falling level often suggests the treatment is working, while a rising level may prompt further investigation. Serial measurements are most informative when taken on the same assay.

What Level of CA 19-9 Indicates Cancer?

There is no single number that confirms cancer. A level above 37 U/mL is considered elevated and warrants further testing, but it is not diagnostic on its own, as benign conditions can also raise CA 19-9. In general, the higher the level, the more likely cancer becomes: at the standard 37 U/mL cut-off, CA 19-9 has a reported sensitivity of approximately 79–81% and specificity of approximately 82–90% for pancreatic cancer in patients with symptoms suggestive of the disease. A level above 1000 U/mL is typically strongly associated with pancreatic cancer, though sensitivity is lower at this threshold, meaning a lower reading does not rule out cancer. A diagnosis is made only after imaging, and often a biopsy, reviewed by a specialist.

What Is Considered a High CA 19-9 Level?

Any result above the laboratory upper limit, commonly 37 U/mL, is regarded as high. Mild elevations are frequently due to non-cancerous causes. Levels in the hundreds raise more concern and usually lead to imaging, and levels above 1000 U/mL are strongly associated with pancreatic cancer. Because a high reading has several possible explanations, it should always be interpreted by a doctor in the context of your symptoms and other tests.

Why the Test Is Done and Who Should Get Tested

The CA 19-9 test has four main roles in managing certain cancers: supporting a diagnosis when symptoms or imaging raise concern, detecting recurrence after treatment, giving prognostic information (higher or persistently raised levels can point to more advanced disease), and monitoring how well treatment is working over time.

 

It is most useful for specific groups: people already diagnosed with pancreatic or biliary cancer who need treatment monitoring, those at higher risk such as people with a relevant family history under a surveillance plan, and people with suggestive symptoms that need investigation.

 

Red-flag symptoms that may prompt testing include:

  • Yellowing of the skin or eyes (jaundice)
  • Unexplained weight loss or loss of appetite
  • Persistent upper abdominal or back pain
  • New-onset diabetes without an obvious cause, alongside other symptoms

 

These symptoms have many possible causes and do not mean cancer is present. They simply warrant a medical review.

How the Test Works and Preparing for It

The CA 19-9 test is a routine blood draw. In brief:

  • A small blood sample is taken from a vein in your arm.
  • The sample is analysed in a laboratory to measure the CA 19-9 level.
  • Results are usually available within a few working days and discussed with you by your doctor.
  • If you are on treatment, the test may be repeated to track changes over time.

No special preparation is usually needed. Tell your doctor about any medicines or supplements you take, and follow any fasting instruction if one is given. The blood draw itself takes a few minutes and carries only minor risks, such as slight bruising at the puncture site.

CA 19-9 and Other Tumour Markers

CA 19-9 is often considered alongside other tumour markers, because no single marker is sufficient on its own.

 

Marker Commonly associated with
CA 19-9 Pancreatic and biliary cancers; used mainly for monitoring and to support diagnosis.
CEA (carcinoembryonic antigen) Colorectal cancer and some other cancers; sometimes used together with CA 19-9.
CA 125 Ovarian cancer; not interchangeable with CA 19-9.

 

Your doctor decides which markers are relevant. You can read more about the CEA tumour marker test and the Cancer Screening and Endoscopy Centre for related information.

CA 19-9 in Singapore: Local Context

Pancreatic and biliary cancers are an important cause of cancer-related illness in Singapore, and they are often diagnosed at a later stage because early symptoms are vague. This is part of why markers such as CA 19-9, used together with imaging and specialist review, have a place in diagnosis and monitoring here.

If you are arranging a test or follow-up locally, FeM Surgery specialists work across the Gallstone and Liver Centre, the Cancer Screening and Endoscopy Centre] and the Colorectal Centre.

If you have a CA 19-9 result you would like reviewed, you can arrange a consultation with a FeM Surgery specialist in Singapore.

Book a Consultation

Limitations of the CA 19-9 Test

CA 19-9 is useful but has clear limits, which is why it is generally not used in isolation:

Variable sensitivity and specificity

It can be raised in benign disease and normal in early cancer, so it is not suitable for general screening.

Not diagnostic alone

An elevated level can have many causes and must be combined with imaging and clinical assessment.

Lewis-negative individuals

People who do not produce CA 19-9 may have a low or undetectable result despite disease.

Benign causes of elevation

Pancreatitis, cholangitis, gallstones, jaundice and liver disease can all raise the level.

Best read as a trend

For monitoring, the direction of change over time is more informative than a single value.

What to Do If Your Result Is High

An elevated CA 19-9 is not a diagnosis, and many people with a raised level do not have cancer. The sensible next step is a calm, structured review with a doctor, who will consider your symptoms and history and may arrange imaging such as an ultrasound, CT or MRI, and in some cases a biopsy. If you are already in treatment, your team will look at the trend rather than one figure.

Interpreting a CA 19-9 result is best done with a doctor. If you would like yours reviewed, a FeM Surgery specialist can talk you through it and advise on next steps.

Book a consultation

CA 19-9 Test Cost in Singapore and Where to Get Tested

Costs vary depending on whether CA 19-9 is ordered on its own, added to a health-screening panel, or arranged as part of a specialist consultation and work-up. As a general guide for Singapore, CA 19-9 added to a screening panel is often a modest add-on cost, while a stand-alone test arranged through a clinic will also include venepuncture and, where relevant, a consultation fee. The figures below are indicative only and are subject to change.

 

Scenario Indicative guidance
CA 19-9 as a panel add-on Commonly a small add-on within a wider tumour-marker or health-screening package.
Stand-alone CA 19-9 with consultation Higher, because it includes the consultation and blood draw. Your final fee depends on the tests and review required.
Medisave / insurance Routine tumour-marker screening is generally not Medisave-claimable; coverage can differ when testing is part of investigating symptoms or a diagnosed condition. Our clinic staff can advise on your situation.

CA 19-9 Tumour Marker Test

Frequently Asked
Questions

What level of CA 19-9 indicates cancer?

There is no single cut-off that confirms cancer. A level above 37 U/mL is elevated and warrants further testing, but benign conditions can also raise it. A level above 1000 U/mL is often strongly associated with pancreatic cancer. Diagnosis is typically confirmed with imaging, and often a biopsy, reviewed by a specialist.

What is a normal CA 19-9 range, and why do ranges differ between laboratories?

A reading under 37 U/mL is commonly considered normal, though some laboratories report a slightly different interval depending on the assay and analyser used. Because methods vary, you should read your own laboratory report and have it interpreted by your doctor.

What is considered a high CA 19-9 level?

Any value above the laboratory upper limit, commonly 37 U/mL, is high. Mild elevations are often due to non-cancerous causes, while levels above 1000 U/mL are strongly associated with pancreatic cancer.

Can CA 19-9 be normal even if cancer is present?

Yes. Around 5 to 10 percent of people are Lewis-negative and produce little or no CA 19-9, so the test can read low or undetectable despite disease. A normal result does not rule out cancer, which is why CA 19-9 is typically used alongside other tests.

What non-cancerous conditions can raise CA 19-9?

Pancreatitis, gallstones, cholangitis, jaundice, liver disease and some other benign conditions can all raise CA 19-9. This is one reason the result needs clinical contex

Is CA 19-9 used for cancer screening?

It is not recommended for routine screening of people without symptoms, because it lacks the accuracy needed and can give false positives and false negatives. It is mainly used to support diagnosis and to monitor a known cancer.

How quickly are CA 19-9 results available?

Results are usually ready within a few working days, depending on the laboratory. Your doctor will discuss them with you at a follow-up.

Is the CA 19-9 test claimable under Medisave or insurance?

Routine tumour-marker screening is generally not Medisave-claimable, but coverage can differ when the test is part of investigating symptoms or managing a diagnosed condition. Please speak to our clinic staff about your specific situation and insurance plan.

What should I bring to a consultation about my CA 19-9 result?

Bring your laboratory report, any previous CA 19-9 results, a list of your current medicines, and any relevant imaging or medical records. This helps the specialist interpret your result in context.

Speak to a FeM Surgery specialist about your CA 19-9 result

Arrange a consultation in Singapore to review your result and discuss any next steps.

Book a Consultation

Our clinics are under the following

insurance panels

For Singaporeans, Singapore Permanent Residents and Foreigners.
Please speak to our friendly clinic staff about using your insurance plans.

Reach Out To Us

We are committed to providing a one-stop experience, where you’ll receive a meticulous consultation and high-quality service in a comfortable environment.

Get Started

Book An Appointment





    image

    • Book An Appointment

    • Media Enquiry

    • Partnership Opportunity



    image

    For faster response, Call Us

    (65) 6733 3383